This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: 4Sc Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Svetlana Hamm: Innovator in Cancer Therapy
Introduction
Svetlana Hamm is a prominent inventor based in Eichenau, Germany. She has made significant contributions to the field of cancer therapy through her innovative research and development. Her work focuses on the medical applications of specific compounds that can enhance treatment outcomes for cancer patients.
Latest Patents
Svetlana Hamm holds a patent for a "Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy." This invention relates to the medical uses of an HDAC inhibitor, characterized by a specific general formula, in combination with a CD137 agonist for the treatment of cancer. This groundbreaking approach aims to improve therapeutic efficacy and patient outcomes.
Career Highlights
Svetlana is associated with 4SC AG, a company dedicated to developing innovative therapies for cancer and other serious diseases. Her role at the company has allowed her to contribute to cutting-edge research and the advancement of new treatment modalities.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Svetlana Hamm's work exemplifies the vital role of innovation in the fight against cancer. Her patent and contributions to medical research highlight her commitment to improving patient care through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile